Very high energy electron (VHEE) beams have been proposed as an alternative radiotherapy modality to megavoltage photons; they penetrate deeply without significant scattering in inhomogeneous tissue because of their high relativistic inertia. However, the depth dose distribution of a single, collimated VHEE beam is quasi-uniform, which can lead to healthy tissue being overexposed. This can be largely overcome by focusing the VHEE beam to a small spot. Here, we present experiments to demonstrate focusing as a means of concentrating dose into small volumetric elements inside a target. We find good agreement between measured dose distributions and Monte Carlo simulations. Focused radiation beams could be used to precisely target tumours or hypoxic regions of a tumour, which would enhance the efficacy of radiotherapy. The development of new accelerator technologies may provide future compact systems for delivering these focused beams to tumours, a concept that can also be extended to X-rays and hadrons.
The main objective of radiotherapy is to kill cancer cells while sparing normal tissue from damage1 and minimising the creation of secondary cancers. This is usually achieved through modalities such as volumetric modulated arc therapy (VMAT)2, stereotactic radiosurgery (SRS)3, intra-operative radiation therapy (IORT)4,5 or brachytherapy.6 To reduce irradiation of healthy tissue and ensue complete irradiation of tumours7, dose must be delivered precisely in such a way that it conforms to the tumour shape. A common approach is to physically shield healthy tissue and apply multiple beams to irradiate tumours from different directions8. Megavoltage (MV) X-rays (4–25 MV) are the commonly used radiation for treating cancers. As illustrated in Fig. 1, the depth–dose distribution produced by a single X-ray beam is high at the entrance and reduces exponentially with depth. Proton and ion beams can improve the contrast between the doses in the tumour with that in healthy tissue, especially in the distal region, by taking advantage of the Bragg peak9,10. Better conformity is achieved using a spread out Bragg peak (SOBP) that is produced by varying the beam energy (e.g. from 60 to 110 MeV and 135 to 147 MeV). However, this results in a build-up of an anterior dose11, as shown in Fig. 1. Moreover, the dose distribution is sensitive to tissue density inhomogeneity, which results in range uncertainties12 and potentially under-irradiation of the tumour, or over-irradiation of healthy tissue13.
Over the last 20 years, very high-energy electrons (VHEEs), in the range of 60–250 MeV14, have been considered as a promising alternative to photons for the treatment of deep-seated tumours15,16,17,18,19. Low-energy electrons (<MeV), from current clinical linacs20, have shallow penetration depths and thus are only suitable for treatment of superficial tumours21 or for intra-operative radiotherapy22. VHEEs, in contrast, are very penetrating due to their high inertia, which enables them to reach deep-seated tumours19,23,24,25,26,27. Their dose is characterised by a sharp transverse penumbra and low scattering at tissue interfaces14,23,28, compared with current low-energy clinical electrons29,30. VHEE beams are also relatively easy to form into pencil beams or scan using electromagnet deflectors15. However, VHEE accelerators are currently relatively large and expensive, compared with 4–22 MeV clinical accelerators, but compact VHEE sources should become available with the development of new technologies such as X-band radio-frequency (RF) accelerators31 and laser-plasma wakefield accelerators32,33,34,35,36.
The depth–dose distribution of collimated VHEE beams is nearly uniform19,26 and several methods have been investigated to improve it. Theoretical and experimental studies have shown that lateral scattering of low-energy (<70 MeV) electron beams can be reduced by imposing a longitudinal or transverse magnetic field on the medium37,38,39, which results in a depth–dose profile that resembles a degraded Bragg peak. Recent Monte Carlo (MC) studies have shown that for VHEEs this dose enhancement at depth can be obtained simply by externally focusing the electron beam using a magnetic lens19. As in optics, we define the f-number as f/D, where D is the beam diameter on the focusing optics and f is the focal length of the lens. Here we present experimental measurements of the depth–dose distribution of VHEE beams focused in a water phantom for several f-numbers and electron energies, and compare these results with theoretical predictions.
Results and discussion
The experiment has been performed at the CERN Linear Electron Accelerator for Research (CLEAR) beamline40, which is based on an S-band RF accelerator that delivers quasi-mono-energetic electron beams with energies between 60 and 220 MeV. The experimental layout is shown in Fig. 2 and more details given in Methods. The electron beam is first expanded by making it diverge over a distance of about 3 m using three quadrupole magnets placed after the last RF deflecting cavity (Fig. 2). The beam is then focused by a second quadrupole triplet into a water phantom, which is placed 21.5 cm downstream of the last quadrupole magnet. The magnetic field strength and aperture size of the quadrupoles only allows focusing with a short focal length in one plane, which is chosen to be horizontal. The beam is collimated or diverges slightly in the vertical plane, resulting in a line focus. Symmetric focusing could have been achieved by upgrading the power supplies of the first quadrupole triplet and employing larger aperture quadrupoles in the second triplet. However, this was not possible in the allocated experimental time. After the final quadrupole magnet, the beam passes through a 0.1 mm thick aluminium window into ambient air, and then through an integrating current transformer (ICT - Bergoz, ICT-055-070-5.0, SN 3350), and finally into the phantom. The ICT records the total charge of the beam entering the phantom. The transverse dose profile is measured at different depths in the phantom using a stack of 16 Gafchromic® films (EBT3, Ashland ISP Advanced Materials) spaced by 1 cm, as discussed in Methods.
Measured dose profiles
Figure 3 shows beam for selected irradiated films spaced by 3 cm (every third film apart from the last film, which is spaced by 2 cm). A 3D simulated reconstruction of the dose distribution is also included, which is based on fits of the sizes measured in the horizontal and vertical planes across the whole film stack. The quadrupole magnetic fields are set to produce a focus at a distance of 14 cm for 158 MeV, and f/11.2 and 10 cm for 158 MeV focused with f/12.3 and 201 MeV focused with f/18.2, from the phantom entrance in air, as measured using an optical transition radiation (OTR) screen.
The beam size at the final quadrupole has been varied to obtain different focusing strengths. Here we present results for f/11.2 and f/12.3 (158 MeV), and f/18.2 (201 MeV). Since the CLEAR beamline is not designed for short focal lengths (because of the small diameter of the vacuum pipe), the beam is clipped by the walls of the metal pipe and rectangular drift-chamber in the magnetic spectrometer, resulting in a rectangular beam profile in the vertical plane on the EBT films. In the horizontal plane, the beam profile is approximately Gaussian for f/12.3 and f/18.2, but rectangular for f/11.2. The full-width at half-maximum (FWHM) and depth–dose profiles obtained from the films and FLUKA MC simulations are shown in Fig. 4. The simulated curves are obtained using the beam size measured at the phantom entrance, the focus position in air and the total charge recorded on the ICT monitor, as discussed in Methods. Measurements and simulations show that the maximum of the dose distribution is located about 5–6 cm inside the phantom at a depth corresponding to the position of the beam focus. The smallest spot size measured in the plane where the beam is focused is 3 mm FWHM for 201 MeV energy (Table 1).
Our previous theoretical study showed that for symmetrically focused beams the spot size at the focus decreases with f-number19 along the beam direction and increases in the transverse direction, resulting in an asymmetric shape of the high-dose volumetric element. However, for a line focus, as shown in this study, this effect is obscured. As the beam propagates further into the phantom the transverse shape becomes symmetric due to scattering, which also shifts the focus towards the phantom entrance, with respect to its position in air, by 7.6, 2.3 and 4.0 cm, for f/11.2, f/12.3 and f/18.2, respectively.
Simulations have also been performed for a collimated beam, indicated by the blue curves in Fig. 4, with the beam size corresponding to the FWHM in the plane where the beam is focused. Focusing enhances the peak dose, compared with collimated beams, by 6, 4.2 and 8.2 times for f/11.2, f/12.3 (158 MeV) and f/18.2 (201 MeV), respectively (Table 1). For higher energies, symmetric focus shifts the maximum further into the phantom, while the peak dose decreases due to scattering and therefore becomes lower than for a beam focused in one plane for the same incident beam charge. However, for symmetrically focused beams (the green curves in Fig. 4), the peak dose is more pronounced than for the experimental curves and provides a more favourable dose distribution by reducing the proximal and distal dose.
We measured the depth–dose profile of 158 and 201 MeV electron beams focused into a water phantom, demonstrating on-axis dose enhancement at a depth of 5–6 cm, which validates theoretical predictions that focused VHEE beams concentrate dose into a well-defined volume deep in tissue. The dose delivered to surrounding tissue is distributed over a larger volume, which reduces surface and exit doses compared with collimated beams. At fixed electron energy, the increase of the peak dose is more pronounced for smaller f-numbers (f/11.2 for the results presented here). Symmetrically focused beams would require higher charge, but the peak dose can be delivered deeper into the body. VHEE beams are a promising modality in radiotherapy of deep-seated tumours where other modalities may not be appropriate due to strong scattering at tissue interfaces, high skin dose or weak penetration.
The focusing method can also be used to deliver therapeutic doses at high rates (FLASH41 radiotherapy), a regime accessible with the accelerator at the CLEAR user facility. Treatment can be administered using a single beam, potentially reducing the detrimental effects of irradiating healthy tissue, and therefore lowering the risk of radiation-induced secondary cancers, compared with conventional treatment methods combined with FLASH therapy. Deposition of high dose into a small volume by a single beam can also increase precision. Furthermore, similar geometric effects can be observed with other modalities, such as photons and protons, as shown in Supplementary Fig. 1a, b and c, d, respectively. It has been shown previously that a focused photon beam can be produced simply by passing a focused VHEE beam through a bremsstrahlung converter42. The resulting dose distribution of the focused gamma rays is similar to that of a focused VHEE beam42.
Millimetre long laser-plasma wakefield accelerators43 are currently capable of producing quasi-mono-energetic electron beams44 with a few tens of picocoulomb bunch charge45, femtoseconds bunch durations46,47,48 and in the 100 MeV to GeV energy range49. They have been already used for dosimetry studies using VHEE fields, which show excellent agreement with EBT3 film responses using clinical accelerators26. Most medical accelerators are based on 3 GHz, S-band cavities with accelerating gradients less than 100 M/V. However, X-band linacs, operating at 12 GHz, can have higher accelerating gradients, and are potentially more compact. The experiments presented here have been carried out in a laboratory environment, which differs from a clinical setting. However, production of secondary radiation is largely absent because beam-shaping components, as used in conventional clinical accelerators, are not required. Focusing of the electron beam only requires quadrupole magnets, which do not intercept the beam.
Accelerator and beam focusing system
The experiment has been conducted at the CERN CLEAR beamline. An electron beam with an energy up to 220 MeV is passed through two sets of triplet electromagnetic quadrupoles (EMQs), with specifications given in Table 2, and focused inside a phantom (30 × 30 × 30 cm3 PMMA tank filled with water) mounted on a movable stage to allow precise translation in the direction perpendicular to the beam propagation axis (Fig. 5).
When the phantom is moved out, the electron beam passes through an OTR screen50 mounted on a stage that can also be translated along the beamline axis. This is imaged onto a CCD camera, which enables measurement of the beam envelope in air. The phantom is placed at the end of the beamline and the electron beam profile is measured at different depths using a stack of 16 EBT3 films immersed in water and spaced by 1 cm. These are cut into 21.5 × 6.75 cm2 strips, which enables several shots to be recorded on the same strip simply by moving the phantom transversally. The water phantom entrance is placed 32.8 cm from the centre of the last quadrupole. The electron beam passes through a 0.1 mm thick aluminium window and propagates in air for 21.5 cm, passing through a charge monitor unit prior to the phantom, as shown in Fig. 5a. Measurements were carried out for 158 and 201 MeV electron energies. In each case, the electron beam Twiss parameters51,52 (Table 3) were measured using the quadrupole scan technique53 and the beam transport is optimised using the software package MAD-X54. Reconstructions of the beam envelopes based on beam Twiss parameters and optics for all beam geometries are shown in Supplementary Fig. 2.
As the CLEAR beamline is not designed for short focal lengths, it was decided to focus the beam only in one plane, which produces a line focus at a chosen reference depth (in vacuum) and inside the water phantom. The EMQ settings for all f-numbers are shown in Table 4. The focal length used to calculate the f-number is defined as the distance from the centre of the final quadrupole to the focal spot position.
EBT3 films are irradiated with a charge of 0.92 nC (8 shots) for f/11.2, 0.58 nC (10 shots) for f/12.3 and 0.62 nC (10 shots) for f/18.2, measured with the uncertainty of 2%. After exposure, the films are read using an Epson Expression 10000XL flatbed scanner. The digitised images are processed using a 2D Wiener filter to remove scanner noise. The background is defined as the average pixel value of four regions with dimensions of 5 × 5 pixels at the corners of each spot. The dose is calculated as the peak value using the red colour channel, which provides the most sensitive response up to 8 Gy, using the formula
where netOD is the change in optical density before and after irradiation, given by netOD = log10(PVbefore/PVafter), where PV is a pixel value. The other coefficients are a = 9.1, b = 58 and n = 3.2, obtained by calibrating films from the same batch (lot 06141702) at the Physikalisch-Technische Bundesanstalt (PTB) research accelerator that produces electrons with energies up to 50 MeV55.
Monte Carlo simulations
MC simulations with the code FLUKA56 have been performed to model the depth dose distribution in water for the same configurations as used in the experiments. The beam size at the front of the water tank is taken as the FWHM of the dose profile measured on the corresponding EBT3 film, whereas the focus position is determined from the measurements performed in air using the OTR screen. Simulations show that scattering in air has negligible effect on the position of the focal spot. The OTR diagnostic system was not used to estimate the beam size because it is not configured to store the full 2D beam profile, but only recorded the results of Gaussian fits in the horizontal and vertical plane, respectively. This data was not reliable because the electron beam profile was not Gaussian. The dose deposition is scored using a USRBIN card56 with resolution of 0.025 and 0.079 cm in the transverse and longitudinal directions, respectively. The dose is averaged within the volume of 0.025 × 30 cm2 on the central beam axis. Simulations are performed for 107 histories and 5 cycles. The electron beam is mono-energetic and has a rectangular profile in the vertical plane for all f-numbers. The profile in the horizontal plane is Gaussian for f/12.3 and f/18.2 and rectangular for f/11.2. The PRECISIOn physics setting56 is chosen to provide interaction models for all electromagnetic and nuclear processes that are relevant to the transport of VHEEs, including photonuclear interactions. The threshold for transport and production of delta particles and photons (ECUT, PCUT) is set to 10 keV with the EMCUT card56. Survival probability of a single photon produced via hadronic interactions is set to 0.002. The energy transfer to electrons lower than the threshold is estimated according to the continuous slowing down approximation57.
Data associated with research published in this paper is available at https://doi.org/10.15129/910256bd-3025-4c0d-bbba-faa08018db79
Baskar, R., Dai, J., Wenlong, N., Yeo, R. & Yeoh, K.-W. Biological response of cancer cells to radiation treatment. Front. Mol. Biosci. 1, 24 (2014).
Otto, K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 35, 310–317 (2008).
Kondziolka, D. Current and novel practice of stereotactic radiosurgery. J. Neurosurg. 130, 1789–1798 (2019).
Pilar, A., Gupta, M., Laskar, S. G. & Laskar, S. Intraoperative radiotherapy: review of techniques and results. Ecancermedicalscience 11, 750 (2017).
Sethi, A. et al. Tissue inhomogeneity corrections in low-kV intra-operative radiotherapy (IORT). Transl. Cancer Res. 4, 182–188 (2015).
Skowronek, J. Current status of brachytherapy in cancer treatment - short overview. J. Contemp. Brachyther. 9, 581–589 (2017).
Muz, B., de la Puente, P., Azab, F. & Azab, A. K. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 3, 83–92 (2015).
Schlegel, W., Grosser, K., Häring, P. & Rhein, B. Beam delivery in 3D conformal radiotherapy using multi-leaf collimators. In New Technologies in Radiation Oncology (eds. Schlegel, W. C., Bortfeld, T. & Grosu, A.-L.) 257–266 (Springer, 2006).
Bragg, W. H. & Kleeman, R. On the alpha particles of radium and their loss of range in passing through various atoms and molecules. Philos. Mag. 10, 600–602 (1905).
Lomax, A. J. Charged particle therapy: the physics of interaction. Cancer J. 15, 285–291 (2009).
Bussiere, M. R. & Adams, J. A. Treatment planning for conformal proton radiation therapy. Technol. Cancer Res. Treat. 2, 389–399 (2003).
Kim, D.-H. et al. Proton range verification in inhomogeneous tissue: treatment planning system vs. measurement vs. Monte Carlo simulation. PLoS ONE 13, e0193904 (2018).
Zheng, Y. et al. Range uncertainty in proton therapy: an end-to-end study using various animal tissues. Int. J. Radiat. Oncol. Biol. Phys. 84, S835 (2012).
Papiez, L., DesRosiers, C. & Moskvin, V. Very high energy electrons (50-250 MeV) and radiation therapy. Technol. Cancer Res. Treat. 1, 105–110 (2002).
Bazalova-Carter, M. et al. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans. Med. Phys. 42, 2615–2625 (2015).
Palma, B. et al. Evaluation of the performance of very high-energy electron (VHEE) beams in radiotherapy: five clinical cases. Med. Phys. 42, 3568–3568 (2015).
Palma, B. et al. Assessment of the quality of very high-energy electron radiotherapy planning. Radiother. Oncol. 119, 154–158 (2016).
Schüler, E. et al. Very high-energy electron (VHEE) beams in radiation therapy; Treatment plan comparison between VHEE, VMAT, and PPBS. Med. Phys. 44, 2544–2555 (2017).
Kokurewicz, K. et al. Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements. Sci. Rep. 9, 10837 (2019).
Hogstrom, K. R. & Almond, P. R. Review of electron beam therapy physics. Phys. Med. Biol. 51, R455–R489 (2006).
Diamantopoulos, S. et al. Clinical implementation of total skin electron beam (TSEB) therapy: a review of the relevant literature. Phys. Med. 27, 62–68 (2011).
Calvo, F. A. Intraoperative irradiation: precision medicine for quality cancer control promotion. Radiat. Oncol. 12, 36–41 (2017).
DesRosiers, C., Moskvin, V., Bielajew, A. F. & Papiez, L. 150-250 MeV electron beams in radiation therapy. Phys. Med. Biol. 45, 1781–1805 (2000).
Moskvin, V., Salvat, F., Stewart, D. K. & DesRosiers, C. M. PENELOPE Monte Carlo engine for treatment planning in radiation therapy with very high energy electrons (VHEE) of 150–250 MeV. IEEE Nucl. Sci. Symp. Med. Imaging Conf. 1961–1966, https://doi.org/10.1109/NSSMIC.2010.5874117 (IEEE, 2010).
Subiel, A. et al. Challenges of dosimetry of ultra-short pulsed very high energy electron beams. Phys. Med. 42, 327–331 (2017).
Subiel, A. et al. Dosimetry of very high energy electrons (VHEE) for radiotherapy applications: using radiochromic film measurements and Monte Carlo simulations. Phys. Med. Biol. 59, 5811–5829 (2014).
Kokurewicz, K. et al. Laser-plasma generated very high energy electrons (VHEEs) in radiotherapy. Medical Applications of Laser-Generated Beams of Particles. IV: Review of Progress and Strategies for the Future Vol. 10239 (ed. Ledingham, K. W. D.) UNSP 102390c https://doi.org/10.1117/12.2271183 (SPIE, 2017).
Lagzda, A. et al. Relative insensitivity to inhomogeneities on very high energy electron dose distributions. Proceedings of IPAC 2017. THPVA139. https://doi.org/10.18429/JACoW-IPAC2017-THPVA139 (2017).
Shiu, A. S. & Hogstrom, K. R. Dose in bone and tissue near bone-tissue interface from electron beam. Int. J. Radiat. Oncol. Biol. Phys. 21, 695–702 (1991).
Bova, F. J. Clinical electron beam physics. In Radiation Therapy Physics (ed. Smith, A. R.) 123–138 (Springer, 1995).
Maxim, P. & Loo, B. Pluridirectional high-energy agile scanning electron radiotherapy (PHASER): extremely rapid treatment for early lung cancer. DTIC Document (2015).
Faure, J. et al. A laser-plasma accelerator producing monoenergetic electron beams. Nature 431, 541–544 (2004).
Geddes, C. G. R. et al. High-quality electron beams from a laser wakefield accelerator using plasma-channel guiding. Nature 431, 538–541 (2004).
Mangles, S. P. D. et al. Monoenergetic beams of relativistic electrons from intense laser-plasma interactions. Nature 431, 535–538 (2004).
Labate, L. et al. Toward an effective use of laser-driven very high energy electrons for radiotherapy: feasibility assessment of multi-field and intensity modulation irradiation schemes. Sci. Rep. 10, 17307 (2020).
Jaroszynski, D. A. et al. Radiation sources based on laser-plasma interactions. Philos. Trans. R. Soc. A 364, 689–710 (2006).
Bostick, W. Possible techniques in direct-electron-beam tumor therapy. Phys. Rev. 77, 564 (1950).
Weinhous, M. S., Nath, R. & Schulz, R. J. Enhancement of electron-beam dose distributions by longitudinal magnetic-fields - Monte-Carlo simulations and magnet system optimization. Med. Phys. 12, 598–603 (1985).
Shih, C. High energy electron radiotherapy in a magnetic field. Med. Phys. 2, 9–13 (1975).
Gamba, D. et al. The CLEAR user facility at CERN. Nucl. Instrum. Methods Phys. Res. A 909, 480–483 (2018).
Symonds, P. & Jones, G. FLASH radiotherapy: the next technological advance in radiation therapy? Clin. Oncol. 31, 405–406 (2019).
Brunetti, E. et al. A simple method of producing a focused x-ray beam. Vol. 11036, SPIE Optics & Optoelectronics, (SPIE, 2019).
Tajima, T. & Dawson, J. M. Laser electron accelerator. Phys. Rev. Lett. 43, 267 (1979).
Brunetti, E. et al. Low emittance, high brilliance relativistic electron beams from a laser-plasma accelerator.Phys. Rev. Lett. 105, 215007 (2010).
Li, Y. et al. Generation of 20 kA electron beam from a laser wakefield accelerator. Phys. Plasmas 24, 023108 (2017).
Leemans, W. et al. Multi-GeV electron beams from capillary-discharge-guided subpetawatt laser pulses in the self-trapping regime. Phys. Rev. Lett. 113, 245002 (2014).
Islam, M. et al. Near-threshold electron injection in the laser–plasma wakefield accelerator leading to femtosecond bunches. N. J. Phys. 17, 093033 (2015).
Wiggins, S. et al. Note: Femtosecond laser micromachining of straight and linearly tapered capillary discharge waveguides. Rev. Sci. Instrum. 82, 096104 (2011).
Gonsalves, A. et al. Petawatt laser guiding and electron beam acceleration to 8 GeV in a laser-heated capillary discharge waveguide. Phys. Rev. Lett. 122, 084801 (2019).
Welsch, C., Bravin, E. & Lefevre, T. Investigations of OTR screen surfaces and shapes. 10th European Particle Accelerator Proceedings, EPAC Conf. Proc. C 060626 1220–1222 (CERN, 2006).
Qin, H. & Davidson, R. C. Generalized Courant-Snyder theory for coupled transverse dynamics of charged particles in electromagnetic focusing lattices. Phys. Rev. ST Accel. Beams 12, 064001 (2009).
Qin, H. & Davidson, R. C. A physical parametrization of coupled transverse dynamics based on generalized Courant–Snyder theory and its applications. Phys. Plasmas 16, 050705 (2009).
Skelton, S. Multi-quadrupole scan for emittance determination at PITZ. DESY Summer Student Report (University of St Andrews, 2007).
Deniau, L. & Grote, H. The MAD-X Program. User’s Reference Manual. (ELPH, 2017).
Schuller, A., Makowski, C., Kapsch, R. P., Nolte, R. & Beck, P. MELAF—a 50 MeV electron accelerator facility for research in radiation effects. 17th European Conf. Radiation and its Effects on Components and Systems (RADECS), 239–242 (IEEE, 2017).
Battistoni, G. et al. Overview of the FLUKA code. Ann. Nucl. Energy 82, 10–18 (2015).
Berger, M. J. et al. Report 37: stopping powers for electrons and positrons. J. Int. Commission on Radiation Units and Measurements os19, https://doi.org/10.1093/jicru/os19.2.Report37 (1984).
We acknowledge support of the U.K. EPSRC (grant nos. EP/J018171/1, EP/J500094/1 and EP/N028694/1) and the EC’s LASERLAB-EUROPE (grant nos. 654148 and 871124).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kokurewicz, K., Brunetti, E., Curcio, A. et al. An experimental study of focused very high energy electron beams for radiotherapy. Commun Phys 4, 33 (2021). https://doi.org/10.1038/s42005-021-00536-0
This article is cited by
Sharp dose profiles for high precision proton therapy using strongly focused proton beams
Scientific Reports (2022)
First theoretical determination of relative biological effectiveness of very high energy electrons
Scientific Reports (2021)
Focused VHEE (very high energy electron) beams and dose delivery for radiotherapy applications
Scientific Reports (2021)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.